The role of prevention in oncology practice: Results from a 2004 survey of American Society of Clinical Oncology members

Patricia A. Ganz, Lorna Kwan, Mark R. Somerfield, David S Alberts, Judy E. Garber, Kenneth Offit, Scott M. Lippman

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Purpose: In 2004, the American Society of Clinical Oncology (ASCO) Cancer Prevention Committee surveyed the members to describe involvement in clinical prevention activities. Methods: A previously administered survey, with updated items on genetics, chemoprevention, and survivorship, was mailed to a stratified random sample of 2,000 domestic members and a convenience sample of 3,144 international members. Results: A total of 49.7% of domestic members contacted and survey eligible responded (n = 851). Nonresponders were younger (50.5 v 51.7 years; P < .01); 465 international members responded. Overall, 35% had received formal instruction in cancer prevention and control, and most respondents expected increased use of prevention, screening/early detection, and risk reduction/ genetic counseling in their practices in the next 5 years. Most reported caring for cancer survivors, including providing general medical care. They also either directly provide or refer patients for cancer prevention and control services (eg, cancer screening, tobacco and nutrition counseling, risk reduction, and chemoprevention). Multivariate modeling found fewer perceived barriers to inclusion of cancer prevention activities in clinical practice among those practicing in an academic setting, seeing a higher proportion of patients without a cancer diagnosis, having formal training in prevention and control, expecting an increase in prevention activities in the next 5 years, and providing community advice on prevention. Conclusion: Barriers to the inclusion of cancer prevention and control activities in oncology clinical practice exist. Nevertheless, a substantial proportion of both domestic and international ASCO members report an interest in cancer prevention and control activities, with a desire for more specific educational programs in this emerging area of oncology practice.

Original languageEnglish (US)
Pages (from-to)2948-2957
Number of pages10
JournalJournal of Clinical Oncology
Volume24
Issue number18
DOIs
StatePublished - Jun 20 2006
Externally publishedYes

Fingerprint

Neoplasms
Medical Oncology
Chemoprevention
Risk Reduction Behavior
Committee Membership
Surveys and Questionnaires
Genetic Counseling
Early Detection of Cancer
Tobacco
Survivors
Counseling
Survival Rate

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The role of prevention in oncology practice : Results from a 2004 survey of American Society of Clinical Oncology members. / Ganz, Patricia A.; Kwan, Lorna; Somerfield, Mark R.; Alberts, David S; Garber, Judy E.; Offit, Kenneth; Lippman, Scott M.

In: Journal of Clinical Oncology, Vol. 24, No. 18, 20.06.2006, p. 2948-2957.

Research output: Contribution to journalArticle

Ganz, Patricia A. ; Kwan, Lorna ; Somerfield, Mark R. ; Alberts, David S ; Garber, Judy E. ; Offit, Kenneth ; Lippman, Scott M. / The role of prevention in oncology practice : Results from a 2004 survey of American Society of Clinical Oncology members. In: Journal of Clinical Oncology. 2006 ; Vol. 24, No. 18. pp. 2948-2957.
@article{1d5d7fe7e7da47429b388bc69d9e839a,
title = "The role of prevention in oncology practice: Results from a 2004 survey of American Society of Clinical Oncology members",
abstract = "Purpose: In 2004, the American Society of Clinical Oncology (ASCO) Cancer Prevention Committee surveyed the members to describe involvement in clinical prevention activities. Methods: A previously administered survey, with updated items on genetics, chemoprevention, and survivorship, was mailed to a stratified random sample of 2,000 domestic members and a convenience sample of 3,144 international members. Results: A total of 49.7{\%} of domestic members contacted and survey eligible responded (n = 851). Nonresponders were younger (50.5 v 51.7 years; P < .01); 465 international members responded. Overall, 35{\%} had received formal instruction in cancer prevention and control, and most respondents expected increased use of prevention, screening/early detection, and risk reduction/ genetic counseling in their practices in the next 5 years. Most reported caring for cancer survivors, including providing general medical care. They also either directly provide or refer patients for cancer prevention and control services (eg, cancer screening, tobacco and nutrition counseling, risk reduction, and chemoprevention). Multivariate modeling found fewer perceived barriers to inclusion of cancer prevention activities in clinical practice among those practicing in an academic setting, seeing a higher proportion of patients without a cancer diagnosis, having formal training in prevention and control, expecting an increase in prevention activities in the next 5 years, and providing community advice on prevention. Conclusion: Barriers to the inclusion of cancer prevention and control activities in oncology clinical practice exist. Nevertheless, a substantial proportion of both domestic and international ASCO members report an interest in cancer prevention and control activities, with a desire for more specific educational programs in this emerging area of oncology practice.",
author = "Ganz, {Patricia A.} and Lorna Kwan and Somerfield, {Mark R.} and Alberts, {David S} and Garber, {Judy E.} and Kenneth Offit and Lippman, {Scott M.}",
year = "2006",
month = "6",
day = "20",
doi = "10.1200/JCO.2006.05.8321",
language = "English (US)",
volume = "24",
pages = "2948--2957",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "18",

}

TY - JOUR

T1 - The role of prevention in oncology practice

T2 - Results from a 2004 survey of American Society of Clinical Oncology members

AU - Ganz, Patricia A.

AU - Kwan, Lorna

AU - Somerfield, Mark R.

AU - Alberts, David S

AU - Garber, Judy E.

AU - Offit, Kenneth

AU - Lippman, Scott M.

PY - 2006/6/20

Y1 - 2006/6/20

N2 - Purpose: In 2004, the American Society of Clinical Oncology (ASCO) Cancer Prevention Committee surveyed the members to describe involvement in clinical prevention activities. Methods: A previously administered survey, with updated items on genetics, chemoprevention, and survivorship, was mailed to a stratified random sample of 2,000 domestic members and a convenience sample of 3,144 international members. Results: A total of 49.7% of domestic members contacted and survey eligible responded (n = 851). Nonresponders were younger (50.5 v 51.7 years; P < .01); 465 international members responded. Overall, 35% had received formal instruction in cancer prevention and control, and most respondents expected increased use of prevention, screening/early detection, and risk reduction/ genetic counseling in their practices in the next 5 years. Most reported caring for cancer survivors, including providing general medical care. They also either directly provide or refer patients for cancer prevention and control services (eg, cancer screening, tobacco and nutrition counseling, risk reduction, and chemoprevention). Multivariate modeling found fewer perceived barriers to inclusion of cancer prevention activities in clinical practice among those practicing in an academic setting, seeing a higher proportion of patients without a cancer diagnosis, having formal training in prevention and control, expecting an increase in prevention activities in the next 5 years, and providing community advice on prevention. Conclusion: Barriers to the inclusion of cancer prevention and control activities in oncology clinical practice exist. Nevertheless, a substantial proportion of both domestic and international ASCO members report an interest in cancer prevention and control activities, with a desire for more specific educational programs in this emerging area of oncology practice.

AB - Purpose: In 2004, the American Society of Clinical Oncology (ASCO) Cancer Prevention Committee surveyed the members to describe involvement in clinical prevention activities. Methods: A previously administered survey, with updated items on genetics, chemoprevention, and survivorship, was mailed to a stratified random sample of 2,000 domestic members and a convenience sample of 3,144 international members. Results: A total of 49.7% of domestic members contacted and survey eligible responded (n = 851). Nonresponders were younger (50.5 v 51.7 years; P < .01); 465 international members responded. Overall, 35% had received formal instruction in cancer prevention and control, and most respondents expected increased use of prevention, screening/early detection, and risk reduction/ genetic counseling in their practices in the next 5 years. Most reported caring for cancer survivors, including providing general medical care. They also either directly provide or refer patients for cancer prevention and control services (eg, cancer screening, tobacco and nutrition counseling, risk reduction, and chemoprevention). Multivariate modeling found fewer perceived barriers to inclusion of cancer prevention activities in clinical practice among those practicing in an academic setting, seeing a higher proportion of patients without a cancer diagnosis, having formal training in prevention and control, expecting an increase in prevention activities in the next 5 years, and providing community advice on prevention. Conclusion: Barriers to the inclusion of cancer prevention and control activities in oncology clinical practice exist. Nevertheless, a substantial proportion of both domestic and international ASCO members report an interest in cancer prevention and control activities, with a desire for more specific educational programs in this emerging area of oncology practice.

UR - http://www.scopus.com/inward/record.url?scp=33745528138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745528138&partnerID=8YFLogxK

U2 - 10.1200/JCO.2006.05.8321

DO - 10.1200/JCO.2006.05.8321

M3 - Article

C2 - 16702579

AN - SCOPUS:33745528138

VL - 24

SP - 2948

EP - 2957

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 18

ER -